Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
2011 · Nature · 2,039 citations
https://doi.org/10.1038/nature10405
E
Eva Brand
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
197
Papers
8.6K
Citations
45
h-index
111
i10-index
Eva Brand is an academic researcher from University Hospital Münster. The author has contributed to research in topics: Lysosomal Storage Disorders Research & Trypanosoma species research and implications & Hormonal Regulation and Hypertension. The author has an h-index of 45, co-authored 168 publications.
ORCID: 0009-0004-3243-5508Papers by this author
worksGenetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function
2016 · Nature Communications · 527 citations
https://doi.org/10.1038/ncomms10023
Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study
2011 · Human Molecular Genetics · 173 citations
https://doi.org/10.1093/hmg/ddr092
An expert consensus on the recommendations for the use of biomarkers in Fabry disease
2023 · Molecular Genetics and Metabolism · 40 citations
https://doi.org/10.1016/j.ymgme.2023.107585
In Vitro and In Vivo Amenability to Migalastat in Fabry Disease
2020 · Molecular Therapy — Methods & Clinical Development · 39 citations
https://doi.org/10.1016/j.omtm.2020.08.012
Mechanisms of Neutralizing Anti-drug Antibody Formation and Clinical Relevance on Therapeutic Efficacy of Enzyme Replacement Therapies in Fabry Disease
2021 · Drugs · 35 citations
https://doi.org/10.1007/s40265-021-01621-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat